NCT00159653 - A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

Xalacom

DRUG

Xalatan

DRUG

Timolol

Trial Locations (55)

16066

Pfizer Investigational Site, Cranberry Township

27262

Pfizer Investigational Site, High Point

28105

Pfizer Investigational Site, Matthews

28210

Pfizer Investigational Site, Charlotte

28262

Pfizer Investigational Site, Charlotte

28403

Pfizer Investigational Site, Wilmington

29406

Pfizer Investigational Site, North Charleston

29464

Pfizer Investigational Site, Mt. Pleasant

30260

Pfizer Investigational Site, Morrow

30322

Pfizer Investigational Site, Atlanta

30342

Pfizer Investigational Site, Atlanta

30349

Pfizer Investigational Site, Atlanta

32174

Pfizer Investigational Site, Ormond Beach

33603

Pfizer Investigational Site, Tampa

33904

Pfizer Investigational Site, Cape Coral

38119

Pfizer Investigational Site, Memphis

40207

Pfizer Investigational Site, Louisville

49085

Pfizer Investigational Site, Saint Joseph

60430

Pfizer Investigational Site, Homewood

66213

Pfizer Investigational Site, Overland Park

68506

Pfizer Investigational Site, Lincoln

71104

Pfizer Investigational Site, Shreveport

74104

Pfizer Investigational Site, Tulsa

77030

Pfizer Investigational Site, Houston

79106

Pfizer Investigational Site, Amarillo

85032

Pfizer Investigational Site, Phoenix

92064

Pfizer Investigational Site, Poway

96002

Pfizer Investigational Site, Redding

96002-2122

Pfizer Investigational Site, Redding

06810-4004

Pfizer Investigational Site, Danbury

33805-2440

Pfizer Investigational Site, Lakeland

02747

Pfizer Investigational Site, North Dartmouth

68198-5540

Pfizer Investigational Site, Omaha

07103-2499

Pfizer Investigational Site, Newark

11714-5701

Pfizer Investigational Site, Bethpage

10029-6574

Pfizer Investigational Site, New York

15238-3103

Pfizer Investigational Site, Pittsburgh

29464-3060

Pfizer Investigational Site, Mt. Pleasant

T2T 5R6

Pfizer Investigational Site, Calgary

V9R 5B6

Pfizer Investigational Site, Nanaimo

E1C 2N7

Pfizer Investigational Site, Moncton

E2L 1G3

Pfizer Investigational Site, Saint John

E2L 4W3

Pfizer Investigational Site, Saint John

B4V 3N2

Pfizer Investigational Site, Bridgewater

L4M 4S5

Pfizer Investigational Site, Barrie

L6B 1A1

Pfizer Investigational Site, Markham

L5A 4E4

Pfizer Investigational Site, Mississauga

L6H 3P1

Pfizer Investigational Site, Oakville

M4N 3M5

Pfizer Investigational Site, Toronto

M5B 1W8

Pfizer Investigational Site, Toronto

M6H 2H1

Pfizer Investigational Site, Toronto

H1T 2M4

Pfizer Investigational Site, Montreal

H1V 1G5

Pfizer Investigational Site, Montreal

S7K 0M7

Pfizer Investigational Site, Saskatoon

S7K 3H3

Pfizer Investigational Site, Saskatoon

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY